Wockhardt ltd

Powered by.

Being different and making a difference. That sums up the vision, philosophy, conviction and driving force behind Dr. Habil F Khorakiwala who revels in venturing down the road less travelled. He founded Wockhardt in Our investors, Wockhardt shareowners, are an important and valued constituent of the Wockhardt stakeholder universe.

Wockhardt ltd

The Estimates data displayed by Moneycontrol is not a recommendation to buy or sell any securities. The Company advises the users to check with duly registered and qualified advisors before taking any investment decision. The Company or anyone involved with the Company will not accept any liability for loss or damage as a result of reliance on the Estimates data. Note : Support and Resistance level for the day, calculated based on price range of the previous trading day. Note : Support and Resistance level for the week, calculated based on price range of the previous trading week. Note : Support and Resistance level for the month, calculated based on price range of the previous trading month. Read 1 investor views. Posted by : attota. Posted by : ThinkStocks. See More. Which stock to buy and why?

Click here for disclaimer. Retrieved 9 May Wockhardt School Associate Entity.

Wockhardt is an Indian pharmaceutical and biotechnology company headquartered in Mumbai , India. It produces formulations , biopharmaceuticals , nutrition products, vaccines and active pharmaceutical ingredients APIs. Wockhardt was founded by Dr. Habil Khorakiwala in the s. Khorakiwala had acquired Worli Chemical Works [8] in

Habil Khorakiwala founded Wockhardt in A member of the World Economic Forum, Dr. Khorakiwala has held many senior positions as an industry representative, and has been lauded and awarded by various institutions and organisations. He has also served as the President of IPA Indian Pharmaceutical Alliance ; as the Chairman of the Board of Governors at the Centre for Organisation Development in Hyderabad, a non-profit, scientific and industrial research organisation and a recognised doctoral research centre; and as the Chancellor of Jamia Hamdard University, New Delhi, which has emerged as an outstanding institution of higher learning with distinct and focused academic programmes. In , Dr. Independent Director Mr. Aman Mehta has been a Director of the Company since Brar has been associated with the pharmaceutical industry for over four decades with a major stint at Ranbaxy Laboratories, where he rose to become the CEO and Managing Director in the year Brar stepped down from this position in to start his entrepreneurial journey and founded GVK Biosciences Pvt.

Wockhardt ltd

As a research-based pharmaceutical company with a global manufacturing and marketing footprint, we manufacture and supply branded and generic finished formulations, as well as intermediate products like APIs, worldwide. Our presence across the pharmaceutical value chain is complemented by our successful venture in healthcare where we have set up a chain of 6 super specialty tertiary care hospitals with an unmatched reputation for quality and life-saving and life-enhancing medical outcomes. In addition, EMROK is enriched with several other patient-centric features such as freedom from on-therapy safety parameter monitoring and need for dose adjustments in patients with renal and hepatic function impairments as well as minimal drug-drug interaction facilitating co-medication with other drugs without safety or efficacy risk. EMROK is formally approved for acute bacterial skin and skin structure infections including diabetic-foot-infections and concurrent bacteraemia caused by Gram positive pathogens including MRSA. This was scientifically a challenge as the goal was to evolve an oral drug with a pharmacokinetic profile mimicking the injectable WCK and safety commensurate to prolonged treatment required for certain recalcitrant MRSA infections and use in out-patient settings. Safety assessments based on clinical studies approx.

Movies in saco

Marg, Vikhroli West ,","address2":"","address3":"","address4":"","telephone":", ","fax":"","email":"rnt. I have been associated with Wockhardt since All Time High 1, No Earnings Data. Buy Report View Sample. Investor Information. Credit ratings Rating update 10 Oct from fitch. Quarterly Yearly. You will now receive notification when someone reply to this message. Our Products. Industry Pharmaceuticals and Healthcare. Announcements Recent Important Search All.

Wockhardt is an Indian pharmaceutical and biotechnology company headquartered in Mumbai , India. It produces formulations , biopharmaceuticals , nutrition products, vaccines and active pharmaceutical ingredients APIs.

Annual reports Financial Year from bse. While it is a matter of regulatory compliance, we also consider it as good governance and our duty and responsibility, to keep our investors informed and updated regularly about news, events and developments that impact our business and operations. In new drug discovery area, they have developed a number of lead molecules in the anti-infective field. Corporate actions. Khorakiwala had acquired Worli Chemical Works [8] in Get detailed analysis with Moneycontrol Stock Insights. Classifications such as banks and foreign portfolio investors were not available earlier. Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. Habil Khorakiwala in the s. Wockhardt Follow.